HK1062689A1 - High-affinity antagonists of elr-cxc chemokines - Google Patents

High-affinity antagonists of elr-cxc chemokines

Info

Publication number
HK1062689A1
HK1062689A1 HK04103755A HK04103755A HK1062689A1 HK 1062689 A1 HK1062689 A1 HK 1062689A1 HK 04103755 A HK04103755 A HK 04103755A HK 04103755 A HK04103755 A HK 04103755A HK 1062689 A1 HK1062689 A1 HK 1062689A1
Authority
HK
Hong Kong
Prior art keywords
elr
cxc chemokines
affinity antagonists
antagonists
affinity
Prior art date
Application number
HK04103755A
Other languages
English (en)
Inventor
John R Gordon
Fang Li
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of HK1062689A1 publication Critical patent/HK1062689A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Power Steering Mechanism (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
HK04103755A 2001-03-01 2004-05-27 High-affinity antagonists of elr-cxc chemokines HK1062689A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27318101P 2001-03-01 2001-03-01
PCT/CA2002/000271 WO2002070565A2 (en) 2001-03-01 2002-03-01 High-affinity antagonists of elr-cxc chemokines

Publications (1)

Publication Number Publication Date
HK1062689A1 true HK1062689A1 (en) 2004-11-19

Family

ID=23042842

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103755A HK1062689A1 (en) 2001-03-01 2004-05-27 High-affinity antagonists of elr-cxc chemokines

Country Status (11)

Country Link
US (3) US7201895B2 (xx)
EP (1) EP1363944B1 (xx)
JP (1) JP2004534521A (xx)
AT (1) ATE339447T1 (xx)
AU (1) AU2002237136B2 (xx)
CA (1) CA2439452C (xx)
DE (1) DE60214676T2 (xx)
DK (1) DK1363944T3 (xx)
ES (1) ES2274957T3 (xx)
HK (1) HK1062689A1 (xx)
WO (1) WO2002070565A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60214676T2 (de) * 2001-03-01 2007-09-20 University Of Saskatchewan Technologies Inc. Hochaffine antagonisten der elr-cxc chemokine
NZ573657A (en) * 2006-05-16 2011-09-30 Univ Saskatchewan High-affinity peptide antagonists of elr-cxc chemokines
US8252741B2 (en) 2008-02-12 2012-08-28 Gordon John R Uses of modified ELR-CXC chemokine G31P
US8299019B2 (en) * 2008-02-12 2012-10-30 Gordon John R Uses of modified ELR-CXC chemokine G31P to treat cancer
KR101247641B1 (ko) * 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
JP6050763B2 (ja) 2011-03-03 2016-12-21 デノバメド インク． 抗菌性の化合物／アジュバント化合物および方法
EP3011012B1 (en) 2013-06-18 2018-09-12 New York University Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets
US10075024B2 (en) 2015-05-22 2018-09-11 La-Z-Boy Incorporated Apparatus and method for wireless power transfer in furniture
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
CA3045310A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
WO2020106754A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0616615B1 (en) * 1991-12-04 1998-08-12 The Biomedical Research Centre Limited Human interleukin-8 analogs
WO1997000601A2 (en) * 1995-06-20 1997-01-09 Chiron Corporation Polypeptides with interleukin-8 receptor binding
DE60214676T2 (de) 2001-03-01 2007-09-20 University Of Saskatchewan Technologies Inc. Hochaffine antagonisten der elr-cxc chemokine

Also Published As

Publication number Publication date
DK1363944T3 (da) 2007-01-08
US20030077705A1 (en) 2003-04-24
WO2002070565A2 (en) 2002-09-12
AU2002237136B2 (en) 2007-11-01
EP1363944A2 (en) 2003-11-26
CA2439452A1 (en) 2002-09-12
EP1363944B1 (en) 2006-09-13
WO2002070565A9 (en) 2002-10-31
ATE339447T1 (de) 2006-10-15
CA2439452C (en) 2012-05-15
US20070021593A1 (en) 2007-01-25
US7741434B2 (en) 2010-06-22
DE60214676T2 (de) 2007-09-20
DE60214676D1 (de) 2006-10-26
JP2004534521A (ja) 2004-11-18
US7201895B2 (en) 2007-04-10
ES2274957T3 (es) 2007-06-01
WO2002070565A3 (en) 2002-12-19
US20090118469A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
HK1062689A1 (en) High-affinity antagonists of elr-cxc chemokines
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
GB0115862D0 (en) Compounds
AU2002350961A1 (en) Ethylene diamine derivatives and their use as orexin-receptor antagonists
MX341370B (es) Antagonistas anti - beta7 humanizados y usos para los mismos.
EP1357909A4 (en) ANTAGONISTS OF IL-8 RECEPTORS
TW200531679A (en) Methods of modulating cytokine activity; related reagents
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
AU5721301A (en) Zolpidem hemitartrate
AU2002358390A1 (en) Novel compounds
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2004007664A3 (en) Nucleic acid vectors
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2004083381A3 (en) Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants
MXPA04000541A (es) Formulacion liofilizada de 2-metil-tieno-benzodiazepina.
WO2005037236A3 (en) Novel heat shock protein 20-related polypeptides and uses therefor
PL374550A1 (en) Il-17 like molecules and uses thereof
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
ZA200403530B (en) Chemokine receptor antagonists and methods of use thereof.
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130301